Its part of GSK business strategy, the money was pooled in advance to pay an eventual fine but the profit from the sales far out-weights the penalty. The pharma industry is not altruistic and does not care for the end-consumer, what does matter to them is the bottom line, money. Best business practices to achieve higher profit margins unfortunately do not incorporate ethical or moral obligations.

The defined boundaries of medical conditions are been increase yearly at the behest of pharma lobbyists to increase the pool of people that can be potentially diagnosed and become a consumer of their products. Pharma companies are also trying to create overlap in the medical conditions their products treat to increase sales margins and expand into new treatment markets.

These companies are not treating sickness, they are selling sickness.

z